加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
KTE6014 EliKine™ 人白介素-2 ELISA定量试剂盒 Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response. 10.600 Journal for Immunotherapy of Cancer 
KTE6015 EliKine™ 人白介素-4 ELISA定量试剂盒 In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype. 4.700 International Immunopharmacology 
KTE6017 EliKine™ 人白介素-6 ELISA定量试剂盒 Single-cell Sequencing and Multi-omics Integration Reveals a Lipid Metabolism-Based Prognostic Model for 5-Fluorouracil Resistance in Breast Cancer. Cell Conflux 1
KTE6017 EliKine™ 人白介素-6 ELISA定量试剂盒 The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities. 10.100 Cancer Letters 
KTE6017 EliKine™ 人白介素-6 ELISA定量试剂盒 Comprehensive analysis of phagocytosis regulatory genes in bladder cancer: implications for prognosis and immunotherapy. 4.000 Frontiers in Molecular Biosciences 
KTE6018 EliKine™ 人白介素-8 ELISA定量试剂盒 Evaluation of cytotoxicity and anti-inflammatory action of AH-Plus sealer with and without petasin, pachymic acid, curcumin & shilajit: an invitro-study. 3.900 Scientific Reports 
KTE6019 EliKine™ 人白介素-10 ELISA定量试剂盒 Notch signaling pathway regulates the progression of fetal growth restriction through mediating immune dysfunction. 1.900 Biomedical Reports 
KTE6019 EliKine™ 人白介素-10 ELISA定量试剂盒 In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype. 4.700 International Immunopharmacology 
KTE6022 EliKine™ 人白介素-17 ELISA定量试剂盒 In human CD4+ T-Cells, omeprazole suppresses proliferation, downregulates V-ATPase, and promotes differentiation toward an autoimmunity-favoring phenotype. 4.700 International Immunopharmacology
KTE6022 EliKine™ 人白介素-17 ELISA定量试剂盒 Notch signaling pathway regulates the progression of fetal growth restriction through mediating immune dysfunction. 1.900  Biomedical Reports 
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部